Market closedNon-fractional

Mural Oncology plc/MURA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

Ticker

MURA

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Dublin, Ireland

Employees

119

MURA Metrics

BasicAdvanced
$55M
Market cap
-
P/E ratio
-$11.48
EPS
-
Beta
-
Dividend rate
$55M
11.269
11.022
3.12
5.741
-179.96%
0.23
0.23
-0.305
0.32%

What the Analysts think about MURA

Analyst Ratings

Majority rating from 1 analysts.
Buy

MURA Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$31M
-48.07%
Profit margin
0.00%
NaN%

MURA Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 30.83%
QuarterlyAnnual
Q1 24
Q2 24
Actual
-$1.84
-
Expected
-$2.66
-$1.90
Surprise
-30.83%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Mural Oncology plc stock?

Mural Oncology plc (MURA) has a market cap of $55M as of July 14, 2024.

What is the P/E ratio for Mural Oncology plc stock?

The price to earnings (P/E) ratio for Mural Oncology plc (MURA) stock is 0 as of July 14, 2024.

Does Mural Oncology plc stock pay dividends?

No, Mural Oncology plc (MURA) stock does not pay dividends to its shareholders as of July 14, 2024.

When is the next Mural Oncology plc dividend payment date?

Mural Oncology plc (MURA) stock does not pay dividends to its shareholders.

What is the beta indicator for Mural Oncology plc?

Mural Oncology plc (MURA) does not currently have a Beta indicator.

Buy or sell Mural Oncology plc stock

Buy or sell Mural Oncology plc stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing